Chronic treatment with iprindole reduces immobility of rats in the behavioural 'despair' test by activating dopaminergic mechanisms in the brain

C. Berettera, R. Invernizzi, L. Pulvirenti, R. Samanin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Iprindole, 10 mg kg-1 i.p., once daily for 21 days, enhanced the metabolism of dopamine in the frontal cortex and striatum of rats with no effect in the nucleus accumbens 1 h after the last injection. Noradrenaline metabolism in the brainstem and telecephalon was also increased in these conditions. No effect on dopamine or noradrenaline metabolism was seen 24 h after the last injection. The same repeated treatment schedule with iprindole markedly reduced the immobility of rats in the behaviour 'despair' test 1 h after the last injection and the effect was prevented by 0.5 mg kg-1 i.p. haloperidol and 100 mg kg-1 i.p. sulpiride but not by 3 mg kg-1 s.c. prazosin or 5 mg kg-1 i.p. (±)-propranolol. The data show that enhanced metabolism of brain dopamine and noradrenaline is associated with the presence of iprindole during repeated treatment and the effect on dopamine mechanism is important in iprindole's ability to reduct rats' immobility in the behavioural 'despair' test.

Original languageEnglish
Pages (from-to)313-315
Number of pages3
JournalJournal of Pharmacy and Pharmacology
Volume38
Issue number4
Publication statusPublished - 1986

Fingerprint

Iprindole
Dopamine
Norepinephrine
Brain
Injections
Sulpiride
Aptitude
Prazosin
Nucleus Accumbens
Frontal Lobe
Haloperidol
Therapeutics
Propranolol
Brain Stem
Appointments and Schedules

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Chronic treatment with iprindole reduces immobility of rats in the behavioural 'despair' test by activating dopaminergic mechanisms in the brain. / Berettera, C.; Invernizzi, R.; Pulvirenti, L.; Samanin, R.

In: Journal of Pharmacy and Pharmacology, Vol. 38, No. 4, 1986, p. 313-315.

Research output: Contribution to journalArticle

@article{09e1b3fb2e904f8a8ecc6e92ae665786,
title = "Chronic treatment with iprindole reduces immobility of rats in the behavioural 'despair' test by activating dopaminergic mechanisms in the brain",
abstract = "Iprindole, 10 mg kg-1 i.p., once daily for 21 days, enhanced the metabolism of dopamine in the frontal cortex and striatum of rats with no effect in the nucleus accumbens 1 h after the last injection. Noradrenaline metabolism in the brainstem and telecephalon was also increased in these conditions. No effect on dopamine or noradrenaline metabolism was seen 24 h after the last injection. The same repeated treatment schedule with iprindole markedly reduced the immobility of rats in the behaviour 'despair' test 1 h after the last injection and the effect was prevented by 0.5 mg kg-1 i.p. haloperidol and 100 mg kg-1 i.p. sulpiride but not by 3 mg kg-1 s.c. prazosin or 5 mg kg-1 i.p. (±)-propranolol. The data show that enhanced metabolism of brain dopamine and noradrenaline is associated with the presence of iprindole during repeated treatment and the effect on dopamine mechanism is important in iprindole's ability to reduct rats' immobility in the behavioural 'despair' test.",
author = "C. Berettera and R. Invernizzi and L. Pulvirenti and R. Samanin",
year = "1986",
language = "English",
volume = "38",
pages = "313--315",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "4",

}

TY - JOUR

T1 - Chronic treatment with iprindole reduces immobility of rats in the behavioural 'despair' test by activating dopaminergic mechanisms in the brain

AU - Berettera, C.

AU - Invernizzi, R.

AU - Pulvirenti, L.

AU - Samanin, R.

PY - 1986

Y1 - 1986

N2 - Iprindole, 10 mg kg-1 i.p., once daily for 21 days, enhanced the metabolism of dopamine in the frontal cortex and striatum of rats with no effect in the nucleus accumbens 1 h after the last injection. Noradrenaline metabolism in the brainstem and telecephalon was also increased in these conditions. No effect on dopamine or noradrenaline metabolism was seen 24 h after the last injection. The same repeated treatment schedule with iprindole markedly reduced the immobility of rats in the behaviour 'despair' test 1 h after the last injection and the effect was prevented by 0.5 mg kg-1 i.p. haloperidol and 100 mg kg-1 i.p. sulpiride but not by 3 mg kg-1 s.c. prazosin or 5 mg kg-1 i.p. (±)-propranolol. The data show that enhanced metabolism of brain dopamine and noradrenaline is associated with the presence of iprindole during repeated treatment and the effect on dopamine mechanism is important in iprindole's ability to reduct rats' immobility in the behavioural 'despair' test.

AB - Iprindole, 10 mg kg-1 i.p., once daily for 21 days, enhanced the metabolism of dopamine in the frontal cortex and striatum of rats with no effect in the nucleus accumbens 1 h after the last injection. Noradrenaline metabolism in the brainstem and telecephalon was also increased in these conditions. No effect on dopamine or noradrenaline metabolism was seen 24 h after the last injection. The same repeated treatment schedule with iprindole markedly reduced the immobility of rats in the behaviour 'despair' test 1 h after the last injection and the effect was prevented by 0.5 mg kg-1 i.p. haloperidol and 100 mg kg-1 i.p. sulpiride but not by 3 mg kg-1 s.c. prazosin or 5 mg kg-1 i.p. (±)-propranolol. The data show that enhanced metabolism of brain dopamine and noradrenaline is associated with the presence of iprindole during repeated treatment and the effect on dopamine mechanism is important in iprindole's ability to reduct rats' immobility in the behavioural 'despair' test.

UR - http://www.scopus.com/inward/record.url?scp=0022636183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022636183&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 313

EP - 315

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 4

ER -